Stelara 130 mg
Stelara 130 mg is a medicine authorised by Swissmedic under authorisation number 66135. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 June 2017 and the authorisation is valid without a time limit. ATC code L04AC05 places the medicine in the group Immunosuppressants.
| Authorisation number | 66135 |
|---|---|
| Name | Stelara 130 mg |
| Full name | Stelara 130 mg, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AC05 |
| First authorisation | 02 June 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Stelara 130 mg, Konzentrat zur Herstellung einer Infusionslösung | B | 02 June 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L04AC05 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Stelara 130 mg authorised in Switzerland?
Yes. Stelara 130 mg is authorised by Swissmedic under authorisation number 66135, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Stelara 130 mg have?
Stelara 130 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Stelara 130 mg?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.